BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30160788)

  • 1. Effect of the autism-associated lncRNA Shank2-AS on architecture and growth of neurons.
    Luo T; Liu P; Wang XY; Li LZ; Zhao LP; Huang J; Li YM; Ou JL; Peng XQ
    J Cell Biochem; 2019 Feb; 120(2):1754-1762. PubMed ID: 30160788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Autism-Related lncRNA MSNP1AS Regulates Moesin Protein to Influence the RhoA, Rac1, and PI3K/Akt Pathways and Regulate the Structure and Survival of Neurons.
    Luo T; Ou JN; Cao LF; Peng XQ; Li YM; Tian YQ
    Autism Res; 2020 Dec; 13(12):2073-2082. PubMed ID: 33215882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide differential expression of synaptic long noncoding RNAs in autism spectrum disorder.
    Wang Y; Zhao X; Ju W; Flory M; Zhong J; Jiang S; Wang P; Dong X; Tao X; Chen Q; Shen C; Zhong M; Yu Y; Brown WT; Zhong N
    Transl Psychiatry; 2015 Oct; 5(10):e660. PubMed ID: 26485544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association between SHANK2 polymorphisms and susceptibility to autism spectrum disorder.
    Bai Y; Qiu S; Li Y; Li Y; Zhong W; Shi M; Zhu X; Jiang H; Yu Y; Cheng Y; Liu Y
    IUBMB Life; 2018 Aug; 70(8):763-776. PubMed ID: 29934968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHANK2 mutations impair apoptosis, proliferation and neurite outgrowth during early neuronal differentiation in SH-SY5Y cells.
    Unsicker C; Cristian FB; von Hahn M; Eckstein V; Rappold GA; Berkel S
    Sci Rep; 2021 Jan; 11(1):2128. PubMed ID: 33483523
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lutz AK; Pérez Arévalo A; Ioannidis V; Stirmlinger N; Demestre M; Delorme R; Bourgeron T; Boeckers TM
    Front Mol Neurosci; 2021; 14():773571. PubMed ID: 34899182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHANK1 polymorphisms and SNP-SNP interactions among SHANK family: A possible cue for recognition to autism spectrum disorder in infant age.
    Qiu S; Li Y; Bai Y; Shi J; Cui H; Gu Y; Ren Y; Zhao Q; Zhang K; Lu M; Wang Y; Li Y; Zhong W; Zhu X; Liu Y; Cheng Y; Qiao Y; Liu Y
    Autism Res; 2019 Mar; 12(3):375-383. PubMed ID: 30629339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Autism-Associated Long Noncoding RNA MSNP1AS on Neuronal Architecture and Gene Expression in Human Neural Progenitor Cells.
    DeWitt JJ; Grepo N; Wilkinson B; Evgrafov OV; Knowles JA; Campbell DB
    Genes (Basel); 2016 Sep; 7(10):. PubMed ID: 27690106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons.
    Zaslavsky K; Zhang WB; McCready FP; Rodrigues DC; Deneault E; Loo C; Zhao M; Ross PJ; El Hajjar J; Romm A; Thompson T; Piekna A; Wei W; Wang Z; Khattak S; Mufteev M; Pasceri P; Scherer SW; Salter MW; Ellis J
    Nat Neurosci; 2019 Apr; 22(4):556-564. PubMed ID: 30911184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Dosage- and Age-Dependent Differential Transcriptomic Changes in the Prefrontal Cortex of
    Lee S; Kang H; Jung H; Kim E; Lee E
    Front Mol Neurosci; 2021; 14():683196. PubMed ID: 34177464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Role of Non-coding RNAs in Autism Spectrum Disorder.
    Ghafouri-Fard S; Noroozi R; Brand S; Hussen BM; Eghtedarian R; Taheri M; Ebrahimzadeh K
    J Mol Neurosci; 2022 Feb; 72(2):201-216. PubMed ID: 34767189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain region and gene dosage-differential transcriptomic changes in
    Yoo YE; Yoo T; Kang H; Kim E
    Front Mol Neurosci; 2022; 15():977305. PubMed ID: 36311025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro zinc supplementation alters synaptic deficits caused by autism spectrum disorder-associated Shank2 point mutations in hippocampal neurons.
    Vyas Y; Jung Y; Lee K; Garner CC; Montgomery JM
    Mol Brain; 2021 Jun; 14(1):95. PubMed ID: 34167580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and
    Yoo YE; Lee S; Kim W; Kim H; Chung C; Ha S; Park J; Chung Y; Kang H; Kim E
    Front Mol Neurosci; 2021; 14():712576. PubMed ID: 34594187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.
    Berkel S; Tang W; Treviño M; Vogt M; Obenhaus HA; Gass P; Scherer SW; Sprengel R; Schratt G; Rappold GA
    Hum Mol Genet; 2012 Jan; 21(2):344-57. PubMed ID: 21994763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel Shank2 transcriptional variant in Shank2 knockout mouse model of autism spectrum disorder.
    Lee YS; Yu NK; Chun J; Yang JE; Lim CS; Kim H; Park G; Lee JA; Lee K; Kaang BK; Lee JH
    Mol Brain; 2020 Apr; 13(1):54. PubMed ID: 32252796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the Autism Spectrum Disorder Gene
    Ahmad M; Stirmlinger N; Jan I; Stifel U; Lee S; Weingandt M; Kelp U; Bockmann J; Ignatius A; Böckers TM; Tuckermann J
    JBMR Plus; 2023 Feb; 7(2):e10711. PubMed ID: 36751416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.
    Leblond CS; Heinrich J; Delorme R; Proepper C; Betancur C; Huguet G; Konyukh M; Chaste P; Ey E; Rastam M; Anckarsäter H; Nygren G; Gillberg IC; Melke J; Toro R; Regnault B; Fauchereau F; Mercati O; Lemière N; Skuse D; Poot M; Holt R; Monaco AP; Järvelä I; Kantojärvi K; Vanhala R; Curran S; Collier DA; Bolton P; Chiocchetti A; Klauck SM; Poustka F; Freitag CM; Waltes R; Kopp M; Duketis E; Bacchelli E; Minopoli F; Ruta L; Battaglia A; Mazzone L; Maestrini E; Sequeira AF; Oliveira B; Vicente A; Oliveira G; Pinto D; Scherer SW; Zelenika D; Delepine M; Lathrop M; Bonneau D; Guinchat V; Devillard F; Assouline B; Mouren MC; Leboyer M; Gillberg C; Boeckers TM; Bourgeron T
    PLoS Genet; 2012 Feb; 8(2):e1002521. PubMed ID: 22346768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactivity and Hypermotivation Associated With Increased Striatal mGluR1 Signaling in a Shank2 Rat Model of Autism.
    Modi ME; Brooks JM; Guilmette ER; Beyna M; Graf R; Reim D; Schmeisser MJ; Boeckers TM; O'Donnell P; Buhl DL
    Front Mol Neurosci; 2018; 11():107. PubMed ID: 29970986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 1 partially rescues early developmental defects caused by SHANK2 knockdown in human neurons.
    Chen ST; Lai WJ; Zhang WJ; Chen QP; Zhou LB; So KF; Shi LL
    Neural Regen Res; 2020 Dec; 15(12):2335-2343. PubMed ID: 32594058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.